메뉴 건너뛰기




Volumn 15, Issue 3, 2014, Pages 317-328

ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition

Author keywords

EGFR; Erlotinib; HNSCC; K RAS; MAPK ERK; NSCLC; PI 103; PI3K Akt

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; AMPHIREGULIN; CETUXIMAB; ERLOTINIB; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLAVONOID; FURAN DERIVATIVE; KRAS PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; RAS PROTEIN;

EID: 84896505123     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.27311     Document Type: Article
Times cited : (49)

References (39)
  • 1
    • 78649469283 scopus 로고    scopus 로고
    • Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
    • PMID:20848399
    • Sharafinski ME, Ferris RL, Ferrone S, Grandis JR. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 2010; 32:1412-21; PMID:20848399; http://dx.doi.org/10.1002/hed.21365
    • (2010) Head Neck , vol.32 , pp. 1412-1421
    • Sharafinski, M.E.1    Ferris, R.L.2    Ferrone, S.3    Grandis, J.R.4
  • 2
    • 36849032852 scopus 로고    scopus 로고
    • Radiation-induced EGFR-signaling and control of DNA-damage repair
    • DOI 10.1080/09553000701769970, PII 787783391
    • Rodemann HP, Dittmann K, Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol 2007; 83:781-91; PMID:18058366; http://dx.doi.org/10.1080/09553000701769970 (Pubitemid 350219102)
    • (2007) International Journal of Radiation Biology , vol.83 , Issue.11-12 , pp. 781-791
    • Rodemann, H.P.1    Dittmann, K.2    Toulany, M.3
  • 3
    • 84875083480 scopus 로고    scopus 로고
    • Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib
    • PMID:23527257
    • Chen G, Noor A, Kronenberger P, Teugels E, Umelo IA, De Grève J. Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib. PLoS One 2013; 8:e59708; PMID:23527257; http://dx.doi.org/10.1371/journal. pone.0059708
    • (2013) PLoS One , vol.8
    • Chen, G.1    Noor, A.2    Kronenberger, P.3    Teugels, E.4    Umelo, I.A.5    De Grève, J.6
  • 4
    • 79952711946 scopus 로고    scopus 로고
    • Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
    • PMID:21135146
    • Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, Pao W, Ladanyi M, Miller VA. Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. Clin Cancer Res 2011; 17:1616-22; PMID:21135146; http://dx.doi.org/10.1158/1078-0432.CCR-10-2692
    • (2011) Clin Cancer Res , vol.17 , pp. 1616-1622
    • Oxnard, G.R.1    Arcila, M.E.2    Sima, C.S.3    Riely, G.J.4    Chmielecki, J.5    Kris, M.G.6    Pao, W.7    Ladanyi, M.8    Miller, V.A.9
  • 5
    • 24944497744 scopus 로고    scopus 로고
    • Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-smallcell lung cancer treated with chemotherapy alone and in combination with erlotinib
    • PMID:16043828
    • Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, Ince WL, Jänne PA, Januario T, Johnson DH, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-smallcell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 2005; 23:5900-9; PMID:16043828; http://dx.doi.org/10.1200/JCO.2005.02.857
    • (2005) J Clin Oncol , vol.23 , pp. 5900-5909
    • Eberhard, D.A.1    Johnson, B.E.2    Amler, L.C.3    Goddard, A.D.4    Heldens, S.L.5    Herbst, R.S.6    Ince, W.L.7    Jänne, P.A.8    Januario, T.9    Johnson, D.H.10
  • 7
    • 34249860227 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: A meta-analysis based on updated individual patient data from six medical centers in mainland China
    • DOI 10.1097/01.JTO.0000268677.87496.4c, PII 0124389420070500000011
    • Wu YL, Zhong WZ, Li LY, Zhang XT, Zhang L, Zhou CC, Liu W, Jiang B, Mu XL, Lin JY, et al. Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China. J Thorac Oncol 2007; 2:430-9; PMID:17473659; http://dx.doi.org/10.1097/01. JTO.0000268677.87496.4c (Pubitemid 47181698)
    • (2007) Journal of Thoracic Oncology , vol.2 , Issue.5 , pp. 430-439
    • Wu, Y.-L.1    Zhong, W.-Z.2    Li, L.-Y.3    Zhang, X.-T.4    Zhang, L.5    Zhou, C.-C.6    Liu, W.7    Jiang, B.8    Mu, X.-L.9    Lin, J.-Y.10    Zhou, Q.11    Xu, C.-R.12    Wang, Z.13    Zhang, G.-C.14    Mok, T.15
  • 9
    • 70349464846 scopus 로고    scopus 로고
    • Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway
    • PMID:19632948
    • Nguyen KS, Kobayashi S, Costa DB. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. Clin Lung Cancer 2009; 10:281-9; PMID:19632948; http://dx.doi.org/10.3816/CLC.2009.n.039
    • (2009) Clin Lung Cancer , vol.10 , pp. 281-289
    • Nguyen, K.S.1    Kobayashi, S.2    Costa, D.B.3
  • 10
    • 79953024710 scopus 로고    scopus 로고
    • Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer
    • PMID:21258250
    • Ludovini V, Bianconi F, Pistola L, Chiari R, Minotti V, Colella R, Giuffrida D, Tofanetti FR, Siggillino A, Flacco A, et al. Phosphoinositide-3- kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer. J Thorac Oncol 2011; 6:707-15; PMID:21258250; http://dx.doi.org/10.1097/JTO.0b013e31820a3a6b
    • (2011) J Thorac Oncol , vol.6 , pp. 707-715
    • Ludovini, V.1    Bianconi, F.2    Pistola, L.3    Chiari, R.4    Minotti, V.5    Colella, R.6    Giuffrida, D.7    Tofanetti, F.R.8    Siggillino, A.9    Flacco, A.10
  • 12
    • 84896530540 scopus 로고    scopus 로고
    • Prevalence of K-RAS codons 12 and 13 mutations in locally advanced head and neck squamous cell carcinoma and impact on clinical outcomes
    • PMID:23737793
    • Bissada E, Abboud O, Abou Chacra Z, Guertin L, Weng X, Nguyen-Tan PF, Tabet JC, Thibaudeau E, Lambert L, Audet ML, et al. Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes. Int J Otolaryngol 2013; 2013:848021; PMID:23737793; http://dx.doi.org/10.1155/2013/848021
    • (2013) Int J Otolaryngol , vol.2013 , pp. 848021
    • Bissada, E.1    Abboud, O.2    Abou Chacra, Z.3    Guertin, L.4    Weng, X.5    Nguyen-Tan, P.F.6    Tabet, J.C.7    Thibaudeau, E.8    Lambert, L.9    Audet, M.L.10
  • 13
    • 84856013039 scopus 로고    scopus 로고
    • Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma
    • PMID:21953075
    • Hama T, Yuza Y, Suda T, Saito Y, Norizoe C, Kato T, Moriyama H, Urashima M. Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma. Clin Exp Metastasis 2012; 29:19-25; PMID:21953075; http://dx.doi.org/10.1007/s10585-011-9425-5
    • (2012) Clin Exp Metastasis , vol.29 , pp. 19-25
    • Hama, T.1    Yuza, Y.2    Suda, T.3    Saito, Y.4    Norizoe, C.5    Kato, T.6    Moriyama, H.7    Urashima, M.8
  • 16
    • 79961000118 scopus 로고    scopus 로고
    • Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment
    • PMID:21653686
    • Tinhofer I, Klinghammer K, Weichert W, Knödler M, Stenzinger A, Gauler T, Budach V, Keilholz U. Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clin Cancer Res 2011; 17:5197-204; PMID:21653686; http://dx.doi.org/10.1158/1078-0432.CCR-10-3338
    • (2011) Clin Cancer Res , vol.17 , pp. 5197-5204
    • Tinhofer, I.1    Klinghammer, K.2    Weichert, W.3    Knödler, M.4    Stenzinger, A.5    Gauler, T.6    Budach, V.7    Keilholz, U.8
  • 17
    • 0037115610 scopus 로고    scopus 로고
    • Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma
    • Hoa M, Davis SL, Ames SJ, Spanjaard RA. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma. Cancer Res 2002; 62:7154-6; PMID:12499248 (Pubitemid 36025228)
    • (2002) Cancer Research , vol.62 , Issue.24 , pp. 7154-7156
    • Hoa, M.1    Davis, S.L.2    Ames, S.J.3    Spanjaard, R.A.4
  • 19
    • 34548058584 scopus 로고    scopus 로고
    • Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity
    • DOI 10.1158/1541-7786.MCR-06-0297
    • Toulany M, Baumann M, Rodemann HP. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Mol Cancer Res 2007; 5:863-72; PMID:17699110; http://dx.doi.org/10.1158/1541-7786.MCR-06-0297 (Pubitemid 47294813)
    • (2007) Molecular Cancer Research , vol.5 , Issue.8 , pp. 863-872
    • Toulany, M.1    Baumann, M.2    Rodemann, H.P.3
  • 20
    • 81855194075 scopus 로고    scopus 로고
    • K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs
    • PMID:21985943
    • Minjgee M, Toulany M, Kehlbach R, Giehl K, Rodemann HPK-RAS. K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs. Int J Radiat Oncol Biol Phys 2011; 81:1506-14; PMID:21985943; http://dx.doi.org/10.1016/j. ijrobp.2011.05.057
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 1506-1514
    • Minjgee, M.1    Toulany, M.2    Kehlbach, R.3    Giehl, K.4    Rodemann, H.P.K.-R.A.S.5
  • 21
    • 78649831949 scopus 로고    scopus 로고
    • Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells
    • PMID:20857497
    • Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, et al. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells 2010; 28:1930-9; PMID:20857497; http://dx.doi.org/10.1002/stem.521
    • (2010) Stem Cells , vol.28 , pp. 1930-1939
    • Sunayama, J.1    Matsuda, K.2    Sato, A.3    Tachibana, K.4    Suzuki, K.5    Narita, Y.6    Shibui, S.7    Sakurada, K.8    Kayama, T.9    Tomiyama, A.10
  • 22
    • 33847323129 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in lung cancer
    • PMID:17318210
    • Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007; 7:169-81; PMID:17318210; http://dx.doi.org/10.1038/nrc2088
    • (2007) Nat Rev Cancer , vol.7 , pp. 169-181
    • Sharma, S.V.1    Bell, D.W.2    Settleman, J.3    Haber, D.A.4
  • 23
    • 84861203302 scopus 로고    scopus 로고
    • EGFRmutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects
    • PMID:22119437
    • Soria JC, Mok TS, Cappuzzo F, Jänne PA. EGFRmutated oncogene-addicted non-small cell lung cancer: current trends and future prospects. Cancer Treat Rev 2012; 38:416-30; PMID:22119437; http://dx.doi.org/ 10.1016/j.ctrv.2011.10.003
    • (2012) Cancer Treat Rev , vol.38 , pp. 416-430
    • Soria, J.C.1    Mok, T.S.2    Cappuzzo, F.3    Jänne, P.A.4
  • 24
    • 70349850471 scopus 로고    scopus 로고
    • Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer
    • PMID:19530244
    • He C, Liu M, Zhou C, Zhang J, Ouyang M, Zhong N, Xu J. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer. Int J Cancer 2009; 125:2393-9; PMID:19530244; http://dx.doi.org/10.1002/ijc.24653
    • (2009) Int J Cancer , vol.125 , pp. 2393-2399
    • He, C.1    Liu, M.2    Zhou, C.3    Zhang, J.4    Ouyang, M.5    Zhong, N.6    Xu, J.7
  • 25
    • 74249106438 scopus 로고    scopus 로고
    • EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer
    • PMID:19884861
    • Mack PC, Holland WS, Burich RA, Sangha R, Solis LJ, Li Y, Beckett LA, Lara PN Jr., Davies AM, Gandara DR. EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer. J Thorac Oncol 2009; 4:1466-72; PMID:19884861; http://dx.doi.org/10.1097/JTO.0b013e3181bbf239
    • (2009) J Thorac Oncol , vol.4 , pp. 1466-1472
    • MacK, P.C.1    Holland, W.S.2    Burich, R.A.3    Sangha, R.4    Solis, L.J.5    Li, Y.6    Beckett, L.A.7    Lara Jr., P.N.8    Davies, A.M.9    Gandara, D.R.10
  • 27
    • 34249810645 scopus 로고    scopus 로고
    • KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    • DOI 10.1158/1078-0432.CCR-06-3043
    • Massarelli E, Varella-Garcia M, Tang X, Xavier AC, Ozburn NC, Liu DD, Bekele BN, Herbst RS, Wistuba II. KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin Cancer Res 2007; 13:2890-6; PMID:17504988; http://dx.doi.org/10.1158/1078-0432.CCR-06-3043 (Pubitemid 46849563)
    • (2007) Clinical Cancer Research , vol.13 , Issue.10 , pp. 2890-2896
    • Massarelli, E.1    Varella-Garcia, M.2    Tang, X.3    Xavier, A.C.4    Ozburn, N.C.5    Liu, D.D.6    Bekele, B.N.7    Herbst, R.S.8    Wistuba, I.I.9
  • 28
    • 65349189958 scopus 로고    scopus 로고
    • American society of clinical oncology provisional clinical opinion: Testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy
    • PMID:19188670
    • Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 2009; 27:2091-6; PMID:19188670; http://dx.doi.org/10.1200/JCO.2009.21.9170
    • (2009) J Clin Oncol , vol.27 , pp. 2091-2096
    • Allegra, C.J.1    Jessup, J.M.2    Somerfield, M.R.3    Hamilton, S.R.4    Hammond, E.H.5    Hayes, D.F.6    McAllister, P.K.7    Morton, R.F.8    Schilsky, R.L.9
  • 29
    • 79951823579 scopus 로고    scopus 로고
    • Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy
    • PMID:21306997
    • Sunaga N, Shames DS, Girard L, Peyton M, Larsen JE, Imai H, Soh J, Sato M, Yanagitani N, Kaira K, et al. Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. Mol Cancer Ther 2011; 10:336-46; PMID:21306997; http://dx.doi.org/10. 1158/1535-7163.MCT-10-0750
    • (2011) Mol Cancer Ther , vol.10 , pp. 336-346
    • Sunaga, N.1    Shames, D.S.2    Girard, L.3    Peyton, M.4    Larsen, J.E.5    Imai, H.6    Soh, J.7    Sato, M.8    Yanagitani, N.9    Kaira, K.10
  • 30
    • 84887019478 scopus 로고    scopus 로고
    • Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells
    • PMID:23891090
    • Saki M, Toulany M, Rodemann HP. Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells. Radiother Oncol 2013; 108:473-8; PMID:23891090; http://dx.doi.org/10.1016/j.radonc.2013.06.023
    • (2013) Radiother Oncol , vol.108 , pp. 473-478
    • Saki, M.1    Toulany, M.2    Rodemann, H.P.3
  • 31
    • 34247245135 scopus 로고    scopus 로고
    • Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells
    • DOI 10.1593/neo.06823
    • Cengel KA, Voong KR, Chandrasekaran S, Maggiorella L, Brunner TB, Stanbridge E, Kao GD, McKenna WG, Bernhard EJ. Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells. Neoplasia 2007; 9:341-8; PMID:17460778; http://dx.doi.org/10.1593/neo.06823 (Pubitemid 46608301)
    • (2007) Neoplasia , vol.9 , Issue.4 , pp. 341-348
    • Cengel, K.A.1    Voong, K.R.2    Chandrasekaran, S.3    Maggiorella, L.4    Brunner, T.B.5    Stanbridge, E.6    Kao, G.D.7    McKenna, W.G.8    Bernhard, E.J.9
  • 32
    • 34249026448 scopus 로고    scopus 로고
    • Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice
    • DOI 10.1016/j.cell.2007.03.051, PII S009286740700520X
    • Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 2007; 129:957-68; PMID:17540175; http://dx.doi.org/10.1016/j.cell.2007.03.051 (Pubitemid 46802703)
    • (2007) Cell , vol.129 , Issue.5 , pp. 957-968
    • Gupta, S.1    Ramjaun, A.R.2    Haiko, P.3    Wang, Y.4    Warne, P.H.5    Nicke, B.6    Nye, E.7    Stamp, G.8    Alitalo, K.9    Downward, J.10
  • 33
    • 84862649725 scopus 로고    scopus 로고
    • The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms
    • PMID:22215152
    • Ciuffreda L, Di Sanza C, Cesta Incani U, Eramo A, Desideri M, Biagioni F, Passeri D, Falcone I, Sette G, Bergamo P, et al. The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms. J Mol Med (Berl) 2012; 90:667-79; PMID:22215152; http://dx.doi.org/10.1007/s00109-011-0844-1
    • (2012) J Mol Med (Berl) , vol.90 , pp. 667-679
    • Ciuffreda, L.1    Di Sanza, C.2    Cesta Incani, U.3    Eramo, A.4    Desideri, M.5    Biagioni, F.6    Passeri, D.7    Falcone, I.8    Sette, G.9    Bergamo, P.10
  • 34
    • 84876075877 scopus 로고    scopus 로고
    • MEK1 is required for PTEN membrane recruitment, AKT regulation, and the maintenance of peripheral tolerance
    • PMID:23453810
    • Zmajkovicova K, Jesenberger V, Catalanotti F, Baumgartner C, Reyes G, Baccarini M. MEK1 is required for PTEN membrane recruitment, AKT regulation, and the maintenance of peripheral tolerance. Mol Cell 2013; 50:43-55; PMID:23453810; http://dx.doi.org/10.1016/j.molcel.2013.01.037
    • (2013) Mol Cell , vol.50 , pp. 43-55
    • Zmajkovicova, K.1    Jesenberger, V.2    Catalanotti, F.3    Baumgartner, C.4    Reyes, G.5    Baccarini, M.6
  • 37
    • 0036146820 scopus 로고    scopus 로고
    • Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection
    • Eicheler W, Zips D, Dörfler A, Grénman R, Baumann M. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. J Histochem Cytochem 2002; 50:197-204; PMID:11799138; http://dx.doi.org/10.1177/002215540205000207 (Pubitemid 34106758)
    • (2002) Journal of Histochemistry and Cytochemistry , vol.50 , Issue.2 , pp. 197-204
    • Eicheler, W.1    Zips, D.2    Dorfler, A.3    Grenman, R.4    Baumann, M.5
  • 39
    • 14744298238 scopus 로고    scopus 로고
    • Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS
    • DOI 10.1016/j.radonc.2004.11.008
    • Toulany M, Dittmann K, Baumann M, Rodemann HP. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. Radiother Oncol 2005; 74:117-29; PMID:15734199; http://dx.doi.org/ 10.1016/j. radonc.2004.11.008 (Pubitemid 40331868)
    • (2005) Radiotherapy and Oncology , vol.74 , Issue.2 , pp. 117-129
    • Toulany, M.1    Dittmann, K.2    Baumann, M.3    Rodemann, H.P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.